Bon Secours Cancer Institute at St. Francis

Midlothian, Virginia 23114

3 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Oligometastatic Disease, Prostate Cancer, Triple Negative Breast Cancer

Studies at this site

• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — Recruiting now
• TERPS Trial for de Novo Oligometastic Prostate Cancer — Recruiting now
• EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) — Recruiting now